apl. Prof. Dr. Lucie Heinzerling

Medizinische Fakultät Department of Dermatology

Checkpoint inhibitor-induced eosinophilic fasciitis following high eosinophilia associated with complete response (2019) Toussaint F, Hammon M, Erdmann M, Moreira A, Kirchberger MC, Schuler G, Schett G, Heinzerling L Journal article Non-professional phagocytosis: a general feature of normal tissue cells (2019) Seeberg J, Loibl M, Moser F, Schwegler M, Büttner-Herold M, Daniel C, Engel F, et al. Journal article, Original article Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Lipase Elevations and Diabetes under Checkpoint Inhibition - Experience in 80 Patients (2019) Weihkopf D, Satzger I, Zimmer L, Eigentler T, Haessel J, Heinzerling L, Herbst R, et al. Conference contribution Characterization of Patients with inoperable malignant Stage IIIB-D Melanoma (2019) Zaremba A, Weishaupt C, Glutsch V, Schilling B, Loquai C, Rafei-Shamsabadi D, Meiss F, et al. Conference contribution Mycophenolate Mofetil for the Treatment of Ipilimumab-induced Autoimmune Colitis in Patients with metastatic Melanoma (2019) Naoum C, Majenka P, Loquai C, Kaehler K, Heinzerling L, Dudda M, Hassel J Conference contribution ECP as prognostic Marker for Melanoma (2019) Moreira A, Krueckel A, Schuler G, Utikal J, Heinzerling L Conference contribution Successful Treatment of a primary cutaneous aggressive epidermotropic CD8+T-cell Lymphoma with Nivolumab (2019) Toussaint F, Erdmann M, Grosch E, Schuler G, Schliep S, Heinzerling L Conference contribution Vaccination with dendritic Cells for metastasized Uveal Melanoma: immunological and clinical Responses (2019) Moreira A, Gross S, Uslu U, Dörrie J, Kummer M, Schliep S, Sponagl F, et al. Conference contribution